Sana Biotechnology, INC. (SANA) — 8-K Filings

8-K Filings (17)

• Sana Biotechnology Announces CMO Departure, Appoints Interim — Apr 24, 2026 Risk: medium
  Sana Biotechnology, Inc. announced on April 22, 2026, the departure of Dr. Evelyn J. Miller as Chief Medical Officer. The company has appointed Dr. Steve D. Kas
• Sana Biotechnology Files 8-K with Exhibits — Apr 13, 2026 Risk: low
  Sana Biotechnology, Inc. filed an 8-K on April 13, 2026, reporting other events as of April 10, 2026. The filing includes exhibits such as legal opinions and ma
• Sana Biotechnology Announces Board and Executive Changes — Sep 5, 2025 Risk: medium
  Sana Biotechnology, Inc. announced on September 4, 2025, a change in its board of directors and executive compensation arrangements. The filing details the depa
• Sana Biotechnology Announces Board and Executive Compensation Changes — Aug 29, 2025 Risk: medium
  On August 28, 2025, Sana Biotechnology, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing
• Sana Biotechnology Files 8-K on Financials — Aug 11, 2025 Risk: low
  Sana Biotechnology, Inc. filed an 8-K on August 11, 2025, reporting on its results of operations and financial condition. The filing includes financial statemen
• Sana Biotechnology Files 8-K for Material Agreement — Aug 7, 2025 Risk: medium
  On August 6, 2025, Sana Biotechnology, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial s
• Sana Biotechnology Files 8-K on Operations and Other Events — Aug 6, 2025 Risk: medium
  On August 6, 2025, Sana Biotechnology, Inc. filed an 8-K report. The filing indicates the company is providing information regarding its results of operations a
• Sana Biotechnology Files 8-K with Financials — Jun 23, 2025 Risk: low
  On June 23, 2025, Sana Biotechnology, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating routine corporate ac
• Sana Biotechnology Reports on Security Holder Vote — Jun 6, 2025 Risk: low
  Sana Biotechnology, Inc. filed an 8-K on June 6, 2025, reporting on a matter submitted to a vote of its security holders on June 5, 2025. The filing does not pr
• Sana Biotechnology Files 8-K — Jan 13, 2025 Risk: low
  On January 13, 2025, Sana Biotechnology, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits, wi
• Sana Biotechnology Appoints New CEO — Oct 8, 2024 Risk: medium
  Sana Biotechnology, Inc. announced on October 4, 2024, the appointment of Dr. Jay L. D. Bradner as its new Chief Executive Officer, effective immediately. Dr. B
• Sana Biotechnology Announces Board and Executive Changes — Sep 12, 2024 Risk: medium
  Sana Biotechnology, Inc. announced on September 6, 2024, changes related to its board of directors and executive compensation. Specifically, the company reporte
• Sana Biotechnology Reports on Shareholder Vote Matters — Jun 7, 2024 Risk: low
  Sana Biotechnology, Inc. filed an 8-K on June 7, 2024, reporting on matters submitted to a vote of security holders as of June 6, 2024. The filing does not cont
• Sana Biotechnology Appoints New CMO, Adds Directors — Apr 18, 2024 Risk: medium
  Sana Biotechnology, Inc. announced on April 18, 2024, the appointment of Dr. Jay L. D. Ian as Chief Medical Officer and the election of Dr. Ian and Ms. Sarah E.
• Sana Bio Files 8-K on Material Agreement; Details Undisclosed — Feb 8, 2024 Risk: medium
  Sana Biotechnology, Inc. filed an 8-K on February 8, 2024, reporting an "Entry into a Material Definitive Agreement" and "Other Events" that occurred on Februar
• Sana Biotechnology Files 8-K on Operations & Financial Condition — Feb 7, 2024
  Sana Biotechnology, Inc. filed an 8-K on February 7, 2024, to report on its results of operations and financial condition, along with other events. This filing,
• SANA Files 8-K for Regulation FD Disclosure & Exhibits — Jan 9, 2024
  Sana Biotechnology, Inc. filed an 8-K on January 9, 2024, to disclose information under Regulation FD and to file financial statements and exhibits. This filing

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX